Hospitalization for pelvic inflammatory disease: a cost-effectiveness analysis

Kenneth J Smith1, Roberta B Ness, Mark S Roberts

  • 1Section of Decision Sciences and Clinical Systems Modeling, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. smithkj2@upmc.edu

Summary

Hospitalizing young women for pelvic inflammatory disease (PID) is generally not cost-effective. Even with improved complication rates, the expense per quality-adjusted life-year gained often remains high.